| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 6,500 | $18.66 | $121,290.00 | -5.5% | |
| Jul 17, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,100 | $19.81 | $61,411.00 | -2.9% | |
| Jun 20, 2017 | Yoo Stephen | Chief Medical Officer | Sale+OE | 15,000 | $19.68 | $295,157.00 | -88.8% | |
| Jun 20, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 6,500 | $19.68 | $127,901.76 | -2.7% | |
| Jun 15, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,100 | $18.75 | $58,125.00 | -2.8% | |
| May 15, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,100 | $19.07 | $59,117.00 | -2.7% | |
| May 15, 2017 | Hayden Donald J Jr | Director | Sell | 8,599 | $19.04 | $163,724.96 | -100% | |
| May 8, 2017 | Hayden Donald J Jr | Director | Sell | 10,000 | $18.35 | $183,500.00 | -53.8% | |
| May 1, 2017 | Hayden Donald J Jr | Director | Sale+OE | 30,000 | $22.26 | $667,735.58 | -32.4% | |
| Apr 24, 2017 | Mills Kenneth T.81 | President And CEO | Sell | 15,440 | $20.98 | $323,955.30 | -5.8% |